HC BoKwang Industry Co.,Ltd (KOSDAQ:225530)
South Korea · Delayed Price · Currency is KRW 2,110.00
+20.00 (0.96%)
At close: Sep 18, 2026
KOSDAQ:225530 Revenue
HC BoKwang Industry Co.,Ltd had revenue of 14.97B KRW in the quarter ending June 30, 2026, with 46.93% growth. This brings the company's revenue in the last twelve months to 42.89B, down -8.92% year-over-year. In the year 2025, HC BoKwang Industry Co.,Ltd had annual revenue of 38.49B, down -39.74%.
Revenue (ttm)
42.89B
Revenue Growth
-8.92%
P/S Ratio
1.79
Revenue / Employee
461.23M
Employees
93
Market Cap
76.67B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.49B | -25.38B | -39.74% |
| Dec 31, 2024 | 63.88B | -21.58B | -25.26% |
| Dec 31, 2023 | 85.46B | -2.01B | -2.30% |
| Dec 31, 2022 | 87.47B | 15.57B | 21.66% |
| Dec 31, 2021 | 71.90B | 15.00B | 26.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Taewoong Logistics | 1.19T |
| Yura Tech. | 201.21B |
| Poled | 87.58B |
| Alphachips | 83.11B |
| Com2uS Holdings | 80.24B |
| Enzychem Lifesciences | 69.00B |
| Korea New Network | 68.03B |
| Innox | 64.54B |